Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Michalowski Website

Aleksandra M. Michalowski, M.Sc., Ph.D.

Portait Photo of Aleksandra Michalowski
Laboratory of Cancer Biology and Genetics
Staff Scientist
Center for Cancer Research
National Cancer Institute
Building 37, Room 3134B
Bethesda, MD 20892
Phone:  
301.496.4988
Fax:  
301.480.2772
E-Mail:  
MichaloA@mail.nih.gov

Biography

Dr. Aleksandra M. Michalowski received her M.Sc. and Ph.D. in biological sciences from the University of Adam Mickiewicz (UAM) in Poznan, Poland. She completed her postdoctoral training under Dr. Richard Simon at the Biometric Research Branch, Division of Cancer Treatment and Diagnosis, NCI, where she conducted research focusing on statistical analysis and computational programming in cancer genomics. Dr. Michalowski joined the Laboratory of Cancer Biology and Genetics as a staff scientist in 2005.

Research

Dr. Michalowski develops biostatistical and bioinformatic approaches for the design and analysis of preclinical cancer research experiments. Her primary focus is genomic studies, which include integration and biological interpretation of large-scale transcriptional signatures from cancer models and patients across a variety of cancer types (multiple myeloma, breast cancer, melanoma and non-melanoma skin cancers, prostate cancer, and lung cancer), modeling of genomic networks, analysis workflows for next-generation sequencing data, and preclinical development of predictive signatures for cancer treatments. Her most recent project involves development of new algorithms for screening of anti-cancer synergistic drug combinations based on high-throughput in vitro assays. Dr. Michalowski conducts collaborative research within the Laboratory of Cancer Biology and Genetics, the Biometric Research Branch (DCTD), and the National Center for Advancing Translational Sciences (NCATS) at NIH.

Inventions
Gene expression signatures of neoplasm responsiveness to therapy.
PCT Application No. PCT/US2012/064693 NIH (DHHS)
Reference No. E-013-2012/0-PCT-02
National stage filing in progress.

This page was last updated on 7/9/2014.